Literature DB >> 20230180

[Pulsed radiofrequency ablation using perfused needle applicators in an in vitro trial on bovine liver].

Markus Frieser1, Deike Strobel, Stefan Schaber, Thaddaeus Till Wissniowski, Thomas Bernatik, Steffen Adis, Eckhart Georg Hahn, Johannes Marcus Hänsler.   

Abstract

Intermittent energy application seems to have positive effects in achieving necrotic zones. We analyzed different pulse periods (PPs) to optimize this method. A radiofrequency alternating current was delivered via a triple-needle applicator (3 cm distance of each needle) introduced into freshly procured bovine liver. The open applicator system was constantly perfused with physiological NaCl solution (3×80 ml/h, power output was constant 90 W). Radiofrequency current was fed to the individual needle in turn of varying PPs (1, 2, 5, and 7 s) over 15 min. Each experimental run comprised a total of 30 applications and temperature was recorded over time. The largest necrotic diameters were found at PP 1 s (relevant: shortest axial diameter/D in the center of the lesion: 9.27 cm, SD±0.97 cm) (PP 2 s D=8.65 cm, SD±0.95 cm, p=0.021; PP 5 s D=8.35 cm, SD±0.95 cm, p=0.001; PP 7 s D=8.18 cm, SD±0.79 cm, p=0.0001). Neither doubling the perfusion rate nor raising the concentration of the perfusion liquid led at PP 1 s to increased necrotic diameters (p=0.82). Our study shows that reducing the PP to 1 s of an open perfused intermittent radiofrequency ablation system produces significantly larger coagulation volumes in explanted liver tissue reaching necrotic diameters over 9 cm. Neither doubling perfusion rates nor higher concentrated perfusion liquid increase necrotic diameters.

Entities:  

Mesh:

Year:  2010        PMID: 20230180     DOI: 10.1515/BMT.2010.021

Source DB:  PubMed          Journal:  Biomed Tech (Berl)        ISSN: 0013-5585            Impact factor:   1.411


  1 in total

1.  Can tumor coverage evaluated 24 h post-radiofrequency ablation predict local tumor progression of liver metastases?

Authors:  Frederik Vandenbroucke; Jef Vandemeulebroucke; Nico Buls; Ruedi F Thoeni; Johan de Mey
Journal:  Int J Comput Assist Radiol Surg       Date:  2018-04-12       Impact factor: 2.924

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.